Your browser doesn't support javascript.
loading
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
Rijnink, Willemijn Frederique; Stadlbauer, Daniel; Puente-Massaguer, Eduard; Okba, Nisreen M A; Kirkpatrick Roubidoux, Ericka; Strohmeier, Shirin; Mudd, Philip A; Schmitz, Aaron; Ellebedy, Ali; McMahon, Meagan; Krammer, Florian.
Afiliação
  • Rijnink WF; Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Stadlbauer D; Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Puente-Massaguer E; Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Okba NMA; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Kirkpatrick Roubidoux E; Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Strohmeier S; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Mudd PA; Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Schmitz A; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Ellebedy A; Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • McMahon M; Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA.
  • Krammer F; Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA.
J Virol ; 97(11): e0164622, 2023 Nov 30.
Article em En | MEDLINE | ID: mdl-37916834
ABSTRACT
IMPORTANCE Currently, many groups are focusing on isolating both neutralizing and non-neutralizing antibodies to the mutation-prone hemagglutinin as a tool to treat or prevent influenza virus infection. Less is known about the level of protection induced by non-neutralizing antibodies that target conserved internal influenza virus proteins. Such non-neutralizing antibodies could provide an alternative pathway to induce broad cross-reactive protection against multiple influenza virus serotypes and subtypes by partially overcoming influenza virus escape mediated by antigenic drift and shift. Accordingly, more information about the level of protection and potential mechanism(s) of action of non-neutralizing antibodies targeting internal influenza virus proteins could be useful for the design of broadly protective and universal influenza virus vaccines.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Proteínas da Matriz Viral / Proteínas do Nucleocapsídeo / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Proteínas da Matriz Viral / Proteínas do Nucleocapsídeo / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2023 Tipo de documento: Article